Hosted on MSN
PDS Biotechnology secures new patent for PDS0101
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
PRINCETON, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the ...
PRINCETON, N.J. - PDS Biotechnology Corporation (NASDAQ:PDSB) announced Tuesday that the Japan Patent Office has issued Patent No. 7783866 for its PDS0101 cancer immunotherapy, granting broad ...
Princeton Day School finished with the best winning percentage of any team in the Colonial Valley Conference Valley Division a year ago at 13-10, yet finished behind 13-win leaders Steinert and ...
Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback